Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CIR Expert Panel’s June Meeting: Popular Botanicals, Salicylates Among Ingredients Deemed Safe

This article is powered by The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel issued two final safety reports and six tentative reports at its June 4-5 meeting in Washington.

You may also be interested in...



CIR Experts To Take First Look At Brown Algae Ingredients, Strategize For MI/MCI Re-Review

The Cosmetic Ingredient Review’s draft report on brown algae-derived ingredients is up for Expert Panel consideration Sept. 24-25, and five Ginkgo biloba ingredients could receive final safe-as-used sign-off. CIR also seeks the panel’s help in preparing a re-review document for the MI/MCI preservative combination, which is overdue for an updated assessment with usage up significantly since 1992.

CIR’s 2019 Priorities A Botanical Garden; AHPA To Stay Tuned In

The American Herbal Products Association vows to stay abreast of Cosmetic Ingredient Review activities, with ingredients of importance to its members sprinkled throughout the group’s 2019 priority list.

CIR Tables Review Of Preservative PHMB; Industry Maintains Data Is On The Way

The Cosmetic Ingredient Review Expert Panel tabled a draft final report for preservative polyaminopropyl biguanide June 5 to await promised sensitization and exposure data from industry. There is concern that an “insufficient data” decision could prompt reformulations with even more questionable alternatives in a market short on preservative options.

Related Content

Topics

UsernamePublicRestriction

Register

RS121657

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel